Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

Skye will provide funding for the development activities of Arecor with the option to licence rights to nimacimab’s new ...

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and differential GLP-1 responses.

While medications like Wegovy promise quick results, many people still prefer a drug-free path to shedding pounds. Science ...

While weight-loss drugs like Ozempic work by boosting the hormone GLP-1, research shows certain foods and eating habits can naturally do the same. From fibre-rich meals to olive oil and meal timing, ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

Prediabetes is a clinical inflection point and a modifiable risk state. Small shifts in care can translate to big shifts in ...